With generic drug competitors slaying sales of Merck’s (MRK) erstwhile blockbuster asthma and allergic rhinitis medicine Singulair, investors are fretting that new diabetes drugs from Johnson & ...

The new study in Diabetes Care comes more than a year after the initial results of the TECOS trial were presented at the American Diabetes Association Scientific Sessions. An evaluation of results ...

Januvia (sitagliptin) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to manage blood sugar levels in adults with type 2 diabetes, along with changes in ...

Januvia (sitagliptin) is a prescription drug for type 2 diabetes that helps lower blood sugar when combined with diet and exercise. Medicare drug plans usually cover this drug. In fact, starting in ...

Januvia and Janumet are two blockbuster drugs in Merck & Co.’s (MRK) diabetes franchise. The drugs are used to lower the blood sugar level in patients with type-2 diabetes. The combined sales for ...

After years of battling over the patents on blockbuster diabetes drug Januvia, Merck and its generic rival Viatris are ready to put the case to rest. In a recent filing with the U.S. District Court ...

Get all latest & breaking news on Januvia And Janumet. Watch videos, top stories and articles on Januvia And Janumet at moneycontrol.com.

NEW YORK, Oct 17 (Reuters) - Merck & Co said on Wednesday U.S. regulators have approved use of its Januvia diabetes drug in new combinations with other treatments, but noted reports of serious ...

DEAR DR. ROACH: Is Januvia an effective drug for diabetes? What are the side effects? — M.A.A. ANSWER: Sitagliptin (Januvia) is an oral medication for diabetes mellitus. The way it works is ...